143 related articles for article (PubMed ID: 14615455)
1. Uncommon hematologic malignancies. Case 1. Plasmablastic leukemia in HIV-associated multicentric Castleman's disease.
Jung CP; Horster S; Lohse P; Bogner JR; Emmerich B; Goebel FD
J Clin Oncol; 2003 Nov; 21(22):4248-9. PubMed ID: 14615455
[No Abstract] [Full Text] [Related]
2. HHV-8 linked to Kaposi's sarcoma, Castleman's disease and primary effusion lymphoma in a HIV-1-infected man.
Bestawros A; Boulassel MR; Michel RP; Routy JP
J Clin Virol; 2008 Jun; 42(2):179-81. PubMed ID: 18343194
[No Abstract] [Full Text] [Related]
3. Concomitant and fatal HHV-8+ multicentric Castleman's disease and Kaposi's sarcoma in the same lymph node of an HIV- liver transplant patient.
Gaitonde S; Vidanovic V; Ni H
Histopathology; 2007 Jun; 50(7):954-8. PubMed ID: 17543090
[No Abstract] [Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus (KSHV): a new viral pathogen associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Said J
West J Med; 1997 Jul; 167(1):37-8. PubMed ID: 9265864
[No Abstract] [Full Text] [Related]
5. Castleman disease in an HIV-infected patient with Kaposi sarcoma.
Saif MW
AIDS Read; 2001 Nov; 11(11):572-6. PubMed ID: 11789020
[TBL] [Abstract][Full Text] [Related]
6. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma.
Liu W; Lacouture ME; Jiang J; Kraus M; Dickstein J; Soltani K; Shea CR
J Cutan Pathol; 2006 Sep; 33 Suppl 2():46-51. PubMed ID: 16972955
[TBL] [Abstract][Full Text] [Related]
7. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
[TBL] [Abstract][Full Text] [Related]
8. HIV-associated multicentric Castleman's disease.
Stebbing J; Pantanowitz L; Dayyani F; Sullivan RJ; Bower M; Dezube BJ
Am J Hematol; 2008 Jun; 83(6):498-503. PubMed ID: 18260115
[TBL] [Abstract][Full Text] [Related]
9. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
10. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N
AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201
[No Abstract] [Full Text] [Related]
11. Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases.
Buchler T; Dubash S; Lee V; Chilton D; Cartledge J; Isaacson P; Tedder RS; Lee SM
AIDS; 2008 Aug; 22(13):1685-7. PubMed ID: 18670234
[No Abstract] [Full Text] [Related]
12. Human herpesvirus 8 and angiosarcoma: analysis of 40 cases and review of the literature.
Schmid H; Zietz C
Pathology; 2005 Aug; 37(4):284-7. PubMed ID: 16194826
[TBL] [Abstract][Full Text] [Related]
13. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and Kaposi sarcoma.
Martin JN
Adv Dent Res; 2011 Apr; 23(1):76-8. PubMed ID: 21441485
[TBL] [Abstract][Full Text] [Related]
14. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
Schulz TF
J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman's disease.
Bélec L; Authier FJ; Mohamed AS; Soubrier M; Gherardi RK
Clin Infect Dis; 1999 Mar; 28(3):678-9. PubMed ID: 10194095
[No Abstract] [Full Text] [Related]
17. Multicentric Castleman disease, Kaposi sarcoma, hemophagocytic syndrome, and a novel HHV8-lymphoproliferative disorder.
Yates JA; Zakai NA; Griffith RC; Wing EJ; Schiffman FJ
AIDS Read; 2007 Dec; 17(12):596-8, 601. PubMed ID: 18178978
[TBL] [Abstract][Full Text] [Related]
18. Multicentric Castleman's disease: an emerging opportunistic infection.
McCall J; Phillips JC
J Assoc Nurses AIDS Care; 2013; 24(1):88-90. PubMed ID: 22564919
[No Abstract] [Full Text] [Related]
19. High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy.
Lumley S; Madge S; Nugent D; Ainsworth J; Dervisevic S; Schmitt C; Schulz TF; Johnson MA; Cwynarski K; Webster DP
AIDS; 2014 Jul; 28(11):1698-700. PubMed ID: 25197975
[No Abstract] [Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
